Skip to main content
Clinical Trials/CTRI/2021/07/035172
CTRI/2021/07/035172Not yet recruiting未知

Comparing the efficacy of Aprepitant Vs Ondansetron for the prevention of post-operative nausea vomiting (PONV) in patients undergoing posterior fossa craniotomy for excision of tumour causing brainstem compression â?? A double blind randomised controlled Trial.

Christian Medical College0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Not yet recruiting

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • All patients aged between 18-70 years, ASA grade I-III undergoing posterior fossa craniotomy for excision of tumour.

Exclusion Criteria

  • 1. Extremes of age < 18 and > 70 years
  • 3. Patients with known allergies to the drugs being used
  • 4. Patients with QT prolongation (Corrected QTc > 440 sec)
  • 5. Patients with planned/ unplanned postoperative ventilation
  • 6. Patients who are on NG tube or who need NG tube placement post-surgery

Investigators

Similar Trials